Nano-X Imaging Ltd. (NNOX) has released an update.
Nano-X Imaging Ltd. reported a rise in Q4 2023 revenue to $2.4 million, marking progress with several U.S. installations of its Nanox.ARC medical imaging systems and the launch of AI-driven diagnostics. The company significantly reduced its net loss from the previous year’s quarter, highlighting advancements in both its commercial and technological development. With these achievements, Nano-X is focusing on expanding its market presence and enhancing patient care with its innovative medical solutions.
For further insights into NNOX stock, check out TipRanks’ Stock Analysis page.
